ask="2.24"
ask_size="200"
average_daily_volume="1076350"
bid="2.17"
bid_size="1400"
book_value="1.72"
change="-0.04"
change_from_200_day_moving_average="-0.69"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-3.77"
change_From_52_week_low="1.95"
change_in_percent="-1.79%"
close="2.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.25"
ebitda="-3.16M"
eps_estimate_current_year="-1.75"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.85"
ex_dividend_date="N/A"
float_shares="7579000"
high="2.23"
high_52_weeks="5.97"
last_trade_date="2/8/2017"
last_trade_price="2.20"
last_trade_size="1045"
last_trade_time="4:00pm"
low="2.16"
low_52_weeks="0.25"
market_capitalization="33.86M"
moving_average_200_day="2.89"
moving_average_50_day="2.12"
name="Eleven Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="12.00"
open="2.21"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.82%"
percent_change_from_50_day_moving_average="+3.89%"
percent_change_from_52_week_high="-63.15%"
percent_change_from_52_week_low="+776.14%"
previous_close="2.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.31"
price_per_sales="1.16"
revenue="29.72M"
shares_outstanding="15393000"
short_ratio="2.79"
stock_exchange="NGM"
symbol="EBIO"
volume="172768"
weeks_range_52="0.25 - 5.97"
